BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21498885)

  • 21. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
    Smith BC; Denu JM
    J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the calcium-mobilizing activity of cyclic ADP-ribose.
    De Flora A; Guida L; Franco L; Zocchi E; Bruzzone S; Benatti U; Damonte G; Lee HC
    J Biol Chem; 1997 May; 272(20):12945-51. PubMed ID: 9148900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-step, nonenzymatic synthesis of O-acetyl-ADP-ribose and analogues from NAD and carboxylates.
    Szczepankiewicz BG; Koppetsch KJ; Perni RB
    J Org Chem; 2011 Aug; 76(16):6465-74. PubMed ID: 21639110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.
    Tanner KG; Landry J; Sternglanz R; Denu JM
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14178-82. PubMed ID: 11106374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases.
    Borra MT; O'Neill FJ; Jackson MD; Marshall B; Verdin E; Foltz KR; Denu JM
    J Biol Chem; 2002 Apr; 277(15):12632-41. PubMed ID: 11812793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.
    Sauve AA; Celic I; Avalos J; Deng H; Boeke JD; Schramm VL
    Biochemistry; 2001 Dec; 40(51):15456-63. PubMed ID: 11747420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serine ADP-ribosylation reversal by the hydrolase ARH3.
    Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
    Elife; 2017 Jun; 6():. PubMed ID: 28650317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bypassing Sir2 and O-acetyl-ADP-ribose in transcriptional silencing.
    Chou CC; Li YC; Gartenberg MR
    Mol Cell; 2008 Sep; 31(5):650-9. PubMed ID: 18775325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
    Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
    J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mono-ADP-Ribosylhydrolase Assays.
    Abplanalp J; Hopp AK; Hottiger MO
    Methods Mol Biol; 2018; 1813():205-213. PubMed ID: 30097869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and biochemical analysis of human ADP-ribosyl-acceptor hydrolase 3 reveals the basis of metal selectivity and different roles for the two magnesium ions.
    Pourfarjam Y; Ma Z; Kurinov I; Moss J; Kim IK
    J Biol Chem; 2021; 296():100692. PubMed ID: 33894202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates.
    Chea C; Lee DY; Kato J; Ishiwata-Endo H; Moss J
    bioRxiv; 2023 Feb; ():. PubMed ID: 36945431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
    Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
    Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.
    Jackson MD; Schmidt MT; Oppenheimer NJ; Denu JM
    J Biol Chem; 2003 Dec; 278(51):50985-98. PubMed ID: 14522996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and Biophysical Assays of PAR-WWE Domain Interactions and Production of iso-ADPr for PAR-Binding Analysis.
    Wang Z; Xu W
    Methods Mol Biol; 2018; 1813():65-73. PubMed ID: 30097861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
    Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.